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Although the factors regulatingmuscle cell differenti-
ation are well described, we know very little about
how differentiating muscle fibers are organized into
individual muscle tissue bundles. Disruption of these
processes leads to muscle hypoplasia or dysplasia,
and replicating these events is vital in tissue engi-
neering approaches. We describe the progressive
cellular events that orchestrate the formation of indi-
vidual limbmuscle bundles and directly demonstrate
the role of the connective tissue cells that surround
muscle precursors in controlling these events. We
show how disruption of gene activity within or
genetic ablation of connective tissue cells impacts
muscle precursors causing disruption of muscle
bundle formation and subsequent muscle dysplasia
and hypoplasia. We identify several markers of the
populations of connective tissue cells that surround
muscle precursors and provide a model for how ma-
trix-modifying proteoglycans secreted by these cells
may influence muscle bundle formation by effects on
the local extracellular matrix (ECM) environment.
INTRODUCTION
Three main tissues comprise the musculoskeletal unit: bones,
muscles, and tendons. Unlike the bones and tendons of the
limb, which are derived from the lateral plate mesoderm, the
limb musculature is formed from muscle precursors that origi-
nate in the hypaxial domain of the somites adjacent to the limb
andmigrate into the limb bud periphery where theymeet the resi-
dent precursors of the bones and tendons, to which they ulti-
mately connect (Buckingham et al., 2003; Kardon, 2011). After
muscle precursors have entered the limb bud, they undergo a
rapid transformation to become organized into individual muscle
bundles. Several studies in chicks have described the process of
organizing dorsal and ventral pre-muscle masses into individual
muscles in the leg (Kardon, 1998; Rodriguez-Guzman et al.,
2007; Schroeter and Tosney, 1991a, 1991b). It is well established3552 Cell Reports 30, 3552–3565, March 10, 2020 ª 2020 The Autho
This is an open access article under the CC BY license (http://creativethat muscle progenitors are autonomously programmed to
undergo muscle differentiation; however, the signals that deter-
mine precisely what type of muscle they will form and, therefore,
their shape and position in the limb are determined by environ-
mental cues produced by cells of the limb bud into which these
muscle precursors migrate (Chevallier et al., 1977; Grim and
Wachtler, 1991; Spornitz, 1978; Kardon et al., 2002). More
recently, in the developing limb buds, muscle connective tissue
(MCT) has been shown to be an important source of such
patterning signals to both nascentmuscles and tendons (Hasson
et al., 2010; Kardon et al., 2003; Mathew et al., 2011; Colasanto
et al., 2016; Swinehart et al., 2013; Vallecillo-Garcı´a et al., 2017).
MCT is a sub-population of irregular connective tissue (ICT) and
named on the basis that it surrounds and is embedded within
nascent muscle tissue. MCT will ultimately contribute to muscle
fascia. Little is known about the cellular and molecular mecha-
nisms that control formation of the, in excess of, 40 individual
muscles that are formed from the stream of muscle precursors
that migrate into the limb. Although there is consensus on the
importance of MCT for muscle morphogenesis, the mechanisms
by which these cells affect muscle and tendon formation during
embryonic development are not understood. This is com-
pounded by the lack of obvious ‘‘pattern’’ in the distribution of
MCT markers, such as Tcf4, that could serve as a template for
where and when individual muscles eventually form and the
paucity of alternative MCT/ICT markers.
Musclemorphogenesis normally occurs reproducibly andwith
high fidelity, as demonstrated by the mirror symmetrical array of
muscles that are present in the left and right limbs of an individual
and in the conserved patterns seen across different vertebrate
species. However, minor variations in the number and placement
of muscles can occur, with a classic example being an absence
of the palmaris longus muscle in the flexor compartment of the
forearm seen in approximately 15% of the population. More clin-
ically significant, many congenital abnormalities have associated
muscle hypoplasias/dysplasias. For example, the upper limb
muscle defects present in Holt-Oram syndrome (HOS OMIM
142900), a dominant disorder associated with mutations in
TBX5 and characterized by upper limb and heart defects (Bas-
son et al., 1997; Li et al., 1997) can be attributed, in part, to
disruption of the MCT/ICT (Hasson et al., 2010). In the majority
of cases, the reasons for muscle dysplasias or hypoplasias arer(s).
commons.org/licenses/by/4.0/).
not understood and it is unclear if the root cause is due to failure
to form a nascent muscle bundle or, alternatively, because form-
ing muscle bundles subsequently degenerate.
A clear understanding of how muscle precursors behave to
form individual muscle bundles is essential before analyzing
the influence of theMCT/ICT in this process. By stage embryonic
day 10.5 (E10.5), all the limbmuscle precursors have entered the
limb bud (Buckingham et al., 2003; Figure 1A). Over the course of
4 days, these cells differentiate into muscle fibers that are orga-
nized into discrete muscle bundles that are the templates of all
the muscles of the adult limb (Figure 1; Delaurier et al., 2008).
Thus, the events of primary myogenesis produce the mature
pattern of individual limbmuscles that enlarge andmature during
subsequent events of secondary and post-natal myogenesis.
There is no single marker described that can label all precursors
throughout this time period. Therefore, to follow how individual
muscle bundles are generated, we used a combination of
MyoD (at E10.5) and myogenin (at E11.5 and later) to mark myo-
blasts and myocytes and myosin to mark the terminally differen-
tiating myocytes and muscle fibers across a time course from
E10.5 until E14.5. For simplicity of presentation, we focus on
the dorsal zeugopodal muscles (extensor compartment of the
forearm), although similar events were observed throughout
the limb musculature (data not shown).
We describe a multistep process that leads to the formation of
distinct muscle bundles. We show that cell orientation, clus-
tering, compaction, and in some cases ‘‘splitting’’ or cleavage
of nascent muscle bundles occur in an overlapping progression
from a common pool of myocyte precursors before secondary
myogenesis starts. Impairing the activity ofMCT/ICT on themus-
cle precursors by deleting Tbx5 from the MCT/ICT or by
depleting these cells produces muscle and tendon patterning
defects. We show that MCT/ICT is required for proper muscle
morphogenesis, supporting previous findings (Hasson et al.,
2010; Kardon, 1998; Mathew et al., 2011). We extend these find-
ings and describe the muscle individuation steps that are
controlled by the activity of MCT. By using tools to genetically
label ICT/MCT and carrying out a transcriptome screen, we iden-
tify several members of the small leucine-rich repeat proteogly-
can (SLRP) family as MCT/ICT markers and that each SLRP
has a unique expression domain in limb ICT, indicating the exis-
tence of MCT/ICT subdomains. Furthermore, we show that the
SLRP expression domains are disrupted in the mouse mutants
following the targeted deletion of Tbx5 in ICT/MCT and that
this precedes the observed muscle-patterning defects.
Together, our results support a model in which spatially distinct
MCT/ICT territories organize cohorts of muscle precursors into
muscle bundles.
RESULTS
Clustering, Orientation, and Fusion of Muscle Cells Are
the First Cellular Events in Muscle Bundle Individuation
Between E10.5 and E12.5, the first wave of myoblast differenti-
ation into post-mitotic, elongated myocytes that fuse to form
multinucleated primary fibers occurs (Abmayr and Pavlath,
2012; Lee et al., 2013). Simultaneously, we detect the first evi-
dence of these muscle precursors being organized, marked bya regular clustering and orientation of myogenin/myosin-positive
myofibers (Figures 1A–1K). MyoD-positive myoblasts (Bucking-
ham and Vincent, 2009; Murphy and Kardon, 2011) are initially
grouped uniformly and with no obvious organization in a central
territory (Figure 1A). An early event is the aggregation of cells into
clusters resulting in the clearing of cells from a central domain
(Figure 1C, arrow). This is further refined by E12 (Figures 1G
and 1J) and E12.5 (Figures 1H and 1K). At E11.75, four prominent
clusters are visible (Figure 1C): proximal (Pr) and posterior (Po)
clusters that contribute to the upper arm (stylopod) muscles,
e.g. biceps, brachialis, and triceps; and anterior (An) and distal
(Di) clusters that contribute to the forearm extensormuscles (Fig-
ures 1C, 1F, and 1G–1L). At E11.75, multinucleated cells are
detected, marking the beginning of myocyte fusion to form my-
ofibers (Figure 1F, arrow); this process continues and by E12.5
the majority of cells are visible as fused myofibers (Figure 1K).
At E12.5, the primary fibers have become aligned with one
another along common orientation planes that prefigure the
position of future muscle bundles (Figures 1K–1M), for example
the extensor carpi radialis (ECR) in the anterior, the extensor dig-
itorum communis (EDC) centrally, and the extensor digitorum lat-
eralis (EDL) in the posterior. By E13, myofibers are organized into
highly ordered and compacted units (Figure 1L), some of which
divide further so by E14.5 all the individual muscles present in
the adult can be distinguished (Figure 1M; Delaurier et al.,
2008). This analysis reveals that prior to the formation of individ-
ual muscle bundles, nascent fibers are organized along distinct
orientation planes and that these orientation planes prefigure
the positions of muscles.
Quantification of Muscle Fiber Orientation
To analyze the emergence of these distinct myofiber units in the
dorsal zeugopod (Figures 2A–2D, boxed region) between E11.5
and E12.5, we labeled early and late myocytes and nascent
fibers by using a combination of RNA in situ hybridization and
immunohistochemistry to detect myogenin and myosin and
used confocal microscopy to scan the result of immunostainings
in dorsal forelimbs (Videos S1, S2, S3, and S4). To quantify the
process of fiber orientation and see the emergence of distinct
myofiber clusters with common orientation planes, cells
expressing both myogenin and myosin were manually outlined
on every optical section of a z stack (Videos S1, S2, S3, and
S4). Projections of these binary files representing each Z plane
were then produced (Figures 2E–2H; see STARMethods). These
projections reveal that at E11.5 the orientation of early myocytes
is not completely random. At E11.75 the An and Di clusters are
becoming more distinguished and cells within each cluster
become progressively more precisely aligned and compacted.
By E12.5, distinct fiber clusters are identifiable both deep and
more superficial. The two deeper clusters are aligned perpendic-
ular to the other myofibers (Figure 2H, asterisks; Video S4).
To further study the processes of cell orientation and clus-
tering and their progressive refinement, we developed a method
to color-code the outlined cells based on their similar orientation
angles. Using the statistical method Central Moments (see STAR
Methods), we derived orientation values (effectively 1–180) and
assigned different colors to value ranges. This enabled us to
identify sub-groups of fiberswithin the limb based on their similarCell Reports 30, 3552–3565, March 10, 2020 3553
Figure 1. Individual Muscle Bundles Form through Progressive Series of Steps
Dorsal view of control forelimbs from E10.5 (A) to E14.5 (M) embryos. Muscle progenitors are detected by in situ hybridization forMyoD (A) orMyogenin (B, C, G,
H, and I) and immunohistochemistry to detectMyosin (E, F, J, K, L, andM). The limbs are oriented fromproximal to distal as shown in the schematic E12.5 forelimb
(D). Arrow in (C) shows an area devoid of myogenin positive cells. Arrow in (F) represents the beginning of myocyte fusion. Individual muscles are identified and
listed in (M).orientation (Figure 2H0). This method transforms the mono-
chrome projections into multi-color images that illustrate the
sequential increase in fiber organization (Figures 2E0–2H0).
At E11.5, the majority of cells are orientated non-randomly3554 Cell Reports 30, 3552–3565, March 10, 2020(anisotropic) diagonally to the Pr-Di axis of the limb (from left to
right in Figure 2). Significantly, this demonstrates that, even early
in the pathway toward muscle bundle formation, myocytes have
some degree of orientation before the formation ofmuscle fibers.
Figure 2. Orientation, Clustering, and Compaction of Nascent Muscle Fibers Prefigure Muscle Bundle Formation and Are Disrupted
Following Conditional Deletion of Tbx5
(A–D) Dorsal view of E11.5 (A), E11.75 (B), E12.0 (C), and E12.5 (D) control forelimbs with muscle cells detected byMyogenin in situ hybridization to illustrate the
region analyzed by immunohistochemistry in (E)–(K). Dotted line squares in (A)–(D) show the approximate area where cell vectors shown in (E)–(H) have been
drawn.
(E–K) Projection of cell vectors drawn from a Z series of confocal scans of limbs at the stages indicated, stained by whole mount immunohistochemistry for
myogenin and myosin in control E11.5 (E), E11.75 (F), E12.0 (G), E12.5 (H), and Tbx5lx/lx;Osr2Cremutant E11.5 (I), E12.0 (J), and E12.5 (K). The vector lines outline
cell orientation.
(E’–K’) Projection of the color-coded cell vectors for control (E’–H’) andmutant (I’–K’) forelimbs. Each cell vector has been assigned a color value corresponding to
a range of angle values from 0 to 180, shown on the rainbow ruler.
Cell Reports 30, 3552–3565, March 10, 2020 3555
Figure 3. Cleavage of Muscle Bundle Is a
Step in the Morphogenesis of Only Some
Muscles
Consecutively staged dorsal views of four E13.5
forelimb zeugopods indicate the progressive
cleavage of the single extensor carpi radialis (ECR)
bundle into two distinct ECR longus and ECR brevis
muscles. Muscles (blue/purple) are stained by
whole-mount immunohistochemistry to detect
Myosin.
(A) In the most immature specimen, cleavage of the
single extensor carpi radialis (ECR) bundle has
started at the distal end (black arrow).
(B) Cleavage extends from distal to proximal and is
almost complete.
(C) Separation of the single bundle into two discrete
units is complete at the proximal end of the bundles
(black arrows).
(D) At the end of the cleavage event, two distinct
ECR longus and ECR brevis bundles are formed.
Scale bar, 200 mm.By E11.75, cellular rearrangements lead to the formation of An
and Di clusters with distinct orientation vectors (Figures 2B
and 2F, labeled yellow and magenta in 2F0). A distal domain is
also emerging with fibers aligning vertically. During subsequent
steps, up to E12.5, fibers become aligned along a common prox-
imal boundary (Figure 2H0, asterisk) but cluster into nascent bun-
dles with their own distinct orientation vectors (labeled yellow,
red, magenta, and blue in Figure 2H0). The distal domain
becomes organized into two distinct clusters (labeled green Fig-
ure 2H0) that prefigure the extensor pollicis longus (EPl), extensor
pollicis brevis (EPb), and extensor indicis proprius muscles (Fig-
ure 1M). A key organization event, therefore, is the alignment of
groups of fibers along particular orientation vectors by E12.5,
which prefigures where muscle bundles form. This process
may enable and/or facilitate these distinct myofiber clusters to
undergo the compaction into defined muscle bundles that occur
at E13.0 (Figure 1L). In summary, these results show that by
E12.5–E13, extensive muscle fiber organization that prefigures
individual muscle bundles is achieved by an overlapping series
of orientation and clustering of muscle precursors, as they differ-
entiate and fuse, rather than by what has previously been
described as muscle splitting, which implies the subdivision of
a coherent, larger domain of cells into smaller groups of cells.
A Minority of Muscles Are Formed through Cleavage of
Visually Distinct Bundles of Muscle Fibers
Some forming muscles undergo a further refinement step that
involves the cleavage of existing, coherent muscle bundles to
form two smaller muscle bundles, a process that resembles a
muscle splitting event. By E13, the ECR precursor bundle is
distinct (Figures 1L and 3A). Over the course of approximately
6–12 h, this bundle divides in two. This starts at the distal end
(Figures 3A and 3B, arrows) and progresses proximally (Figures
3C and 3D, arrows). A similar event (not shown) results in the3556 Cell Reports 30, 3552–3565, March 10, 2020cleavage of a single EP precursor to
form the EPl and EPb, which are distinct
by E14.5 (Figure 1M). In the dorsal zeugo-pod, this mechanism of muscle bundle individuation is limited to
longus and brevis muscles that are closely associated with one
another and share similar origins and insertions.
Osr2IRESCre Is Expressed in ICT, Including MCT
In a previous study using a pan-limb mesenchyme, tamoxifen-
inducible cre, we demonstrated, indirectly, that Tbx5 acts in
MCT to regulate muscle (and tendon) morphogenesis (Hasson
et al., 2010; Gao et al., 2011). To directly assess the function of
Tbx5 in MCT, we sought to identify a cre deleter line that would
enable us to target MCT specifically and genetically label this
population of cells.
The odd-skipped related transcription factors Osr1 and Osr2
are expressed in ICTs, including the MCT in chick and mouse
limbs (Stricker et al., 2006; Vallecillo-Garcı´a et al., 2017). We
used the Osr2IRESCre allele (Lan et al., 2007) (hereafter referred
to asOsr2Cre) to target gene deletion andmarker gene activation
in the limb ICT, including extensive areas of the MCT. The
Osr2Cre produces cre activity in the zeugopod (forearm) region
and is less extensive in more proximal (stylopod and girdle)
domains of the forelimb equivalent to that previously reported
(Figures S1A and S1B). Figures S1 Osr2Cre activity (reported
by GFP expression from the cre-inducible reporter) is excluded
from Sox9-expressing cartilage precursors, with the exception
of a population of joint interzone cells between the humerus
and ulna (FiguresS1C andS1D), consistentwith a previous report
(Gao et al., 2011). This exclusion of staining is confirmed when
dissociated limb bud cells are stained in culture (Figure S1E).
Distinct GFP-expressing or Sox9-expressing cells are detected.
Cre activity is observed in dorsal and ventral domains surround-
ing and embedded within, but not overlapping with, MyoD-
positive muscle precursors at E10.5 (data not shown), E11.5,
and E12.5 (Figures S1F and S1G). This non-overlapping
patterning of GFP and MyoD staining was also confirmed when
dissociated limb bud cells were stained in culture. Significantly,
Osr2Cre activity is detected in Tcf4-positive MCT cells associ-
ated with the dorsal and ventral muscle masses (Figures S1I
and S1J). In dissociated limb bud cells in culture, expression of
Tcf4 is observed in GFP-expressing cells (Figure S1K). However,
the domain of Osr2Cre activity is broader (Figure S1I). Thus,
Osr2Cre targets a wider population of MCT and ICT cells than
that labeled by Tcf4. Tcf4 is also expressed in the distal cartilage
precursors (Figure S1I). We observe Osr2Cre-targeted cells sur-
rounding and interspersed between nascent muscle bundles at
E13.5 (Video S5). In summary, during stages encompassing pri-
mary myogenesis, Osr2Cre targets a population of ICT cells,
including a large portion of MCT that surrounds the limb muscle
precursors but is excluded from the muscle and the great major-
ity of cartilage precursors.
Deletion of Tbx5 by Osr2Cre Produces Muscle and
Tendon Patterning Defects
To directly test the activity of Tbx5 in MCT and demonstrate the
efficacy of the Osr2Cre deleter to target this cell population,
we used the Osr2Cre line to conditionally delete Tbx5 in a
large proportion of limb MCT progenitor cells from E10.5.
Tbx5lx/+;Osr2cre heterozygous embryos have no apparent
phenotype (Figures 4A, 4C, 4E, 4G, 4I, 4K, 4M, and 4O). In
contrast, Tbx5lx/lx;Osr2Cre homozygous conditional mutant
embryos (hereafter referred to asmutants) have defects in mus-
cle morphogenesis (Figures 4B, 4D, 4F, 4H, 4J, 4L, 4N, and 4P).
We used immunofluorescence to examine the morphology and
location of muscles and associated tendons and focused on the
dorsal forearm (zeugopod) muscles in the forelimb. We consis-
tently detect 4 distinct abnormalities in mutant limbs: (1) failure
of muscle bundles to divide to form two distinct muscles, a fail-
ure of cleavage or splitting; (2) formation of smaller, hypoplastic
muscles; (3) absence of a muscle bundle; (4) a larger muscle
bundle; and (5) stray, misaligned fibers (Figure 4). The ECR lon-
gus (ECRl) and ECR brevis (ECRb) are two adjacent muscles in
the radial, posterior compartment of the forearm (Figures 1M, 3,
4G, 4M, and 4O). Instead, a single muscle body with a single
tendon attachment is found in the equivalent location in the
mutant (Figures 4H, 4L (arrowed), 4N, and 4P). Similarly, the
EPl and EPb do not form and a single muscle and tendon is pre-
sent (Figures 4M and 4N). The EDC muscle lies superficial and
central in the forearm (Figure 4E, outlined with dashed line). In
the mutant, this muscle is smaller and lacks the distinctive fusi-
form shape (Figure 4F, outlined with dashed line), although it
attaches to digits 2–5, consistent with the EDC muscle (Figures
4E and 4F). The EDLmuscle lies just below the EDC (Figures 4E,
4I, and 4K, asterisk). This muscle is absent in the mutant (Fig-
ures 4F, 4J, and 4L, asterisk). The extensor carpi ulnaris
(ECU) lies posterior to the EDL and has an associated tendon
that extends to the 5th metacarpal (Figure 4I, arrowhead). In
the mutant, this muscle is larger and the single associated
tendon splits to insert in digit 5 and 4 (Figures 4J and 4L, arrow-
head). One striking observation in mutant limbs at E13.5 is the
presence of stray, misaligned fibers (Figure 4D, arrow), sug-
gesting a degree of disorganization of some nascent fibers as
they begin to aggregate into clusters. These misaligned fibers
appear transient because they are not detected at E14.5
(Figure 4H).Deletion of Tbx5 by Osr2Cre Disrupts Clustering and
Aggregation of Muscle Precursors
To study the origin of the soft tissue abnormalities in the mutant,
westained limbsat earlier stagesbyusingmarkersofmuscle pre-
cursors. Analysis of Pax3 at E10.5 and MyoD and myogenin at
E11.5 showed no differences between the mutant and control
limbs (Figures 5A–5F), but abnormalities can be seen at E12.0
and become more pronounced at E12.5 (Figures 5G–5J).
Notably, some muscle precursors fail to clear from a central
domain of the dorsal forelimbs (Figure 5G–5J and asterisk in
5H). Muscle precursors are more diffuse in the mutant, and
some cells fail to undergo the same degree of clustering and
compaction that help segregate cohorts of muscle precursors.
For example, in the posterior of the limb, these processes lead
to the separation of two domains of muscle precursors (arrow-
heads in Figures 5G and 5I), and this fails to occur at equivalent
stages in the mutant (arrowhead, Figures 5H and 5I). This
abnormal distribution of muscle precursors and fibers is repro-
ducible, suggesting that the abnormal clustering andcompaction
consistently observed at early stages is responsible for the ab-
sent and abnormally shaped muscles that result later (Figure 4).
Disruption of fiber orientation and compaction was apparent
by applying our CentralMoment analysismethod tomutant limbs
stained for myogenin and myosin (Figures 2I–2K0; Videos S6,
S7,andS8) andbycomparing these tocontrol samplesdescribed
earlier (Figures 2A–2H0). Disruption in the extent of orientation is
clearly detectable at E12.0 (Figures 2J and 2J0 compared to Fig-
ures 2G and 2G0) and E12.5 (Figures 2K and 2K0 compared to Fig-
ures 2H and 2H0) in themutant with stray fibers present. Although
similar orientation planes of muscle fibers are observed in the
mutant, these cells are less ordered and less compacted than
control samples.
To compare the effect of disrupting Tbx5 activity in ICT cells to
the effect of depleting ICT cells, we took advantage of the
ROSA26-GFP-DTA (Ivanova et al., 2005) to achieve genetic abla-
tion of ICT by cre-mediated expression of the diphtheria toxin
(DTA). ROSA26-eGFP-DTA;Osr2Cre embryos were not viable
beyond E13.0, which restricted analysis up to this time point.
Analysis of ROSA26-eGFP-DTA;Osr2Cre limbs at E13.0 showed
dramatic disorganization of muscle precursors, more severely
than that observed following deletion of Tbx5 in the ICT (compare
Figure S2 with Figures 4C, 4D, and 5I–5J), suggesting that dele-
tion of Tbx5 perturbs only some aspects of the function of ICT in
muscle morphogenesis and that in the absence of ICT muscle
development is adversely affected.
Despite their abnormal shape and location within the limb,
muscles in the Tbx5lx/lx;Osr2Cre homozygous conditional
mutant do become innervated and can control movement of
the limb skeleton (Video S9). Mutant pups at post-natal day
0 (P0) appear to have difficulty fully pronating the forelimb to plant
the ventral surface of the paw on the surface and instead the paw
is held in amore supine position, often leading to the pupwalking
on the edge or back (dorsal surface) of the paw. These results
definitively demonstrate that Tbx5 acting within the MCT/ICT
has an important influence on the morphogenetic processes
that produce individual muscle bundles and that in the absence
of Tbx5 muscle differentiation and aspects of secondary myo-
genesis, such as muscle growth and innervation, can occur.Cell Reports 30, 3552–3565, March 10, 2020 3557
Figure 4. Deletion of Tbx5 by Osr2Cre Produces Muscle
and Tendon Patterning Defects
Muscles and tendons labeled for myosin and ScxGFP, respec-
tively. Dorsal view of control E13.5 (A and C), E14.5 (E, G, K, M,
and O), and E16.5 (I) forelimbs and equivalent stages of mutant
E13.5 (B and D), E14.5 (F, H, L, N, and P), and E16.5 (J) forelimbs.
Black and white arrows indicate single ECR bundle (H) and a
single tendon (B, F, and L) in mutant. Optical projection tomog-
raphy (OPT) scans of control (K) and mutant (L) limbs at E14.5.
Optical dissection of the ECRl, ECRb, EPl, and EPb of the sample
shown in (K) (M). Equivalent optical dissection of the mutant
shown in (L) showing single ECR and EP bundles (N). Dotted white
lines in (M) and (N) show approximate position of optical slice
through the 3D reconstruction made to generate the top images in
(O) and (P), respectively. Bottom panels in (O) and (P) show rotated
views of ECR to show the 2 tendons of ECRl and ECRb in the
control and the single ECR tendon in the mutant (asterisks).
3558 Cell Reports 30, 3552–3565, March 10, 2020
Figure 5. Muscle Patterning Defects in
Tbx5lx/lx;Osr2CreMutants Are Detected at E12.0
Dorsal view of control (A, C, E, G, and I) and mutant (B,
D, F, H, and J) forelimbs at E10.5 (A andB), E11.5 (C–F),
E12.0 (G and H), and E12.5 (I and J). Muscle cells are
detected by in situ hybridization against Pax3 (A andB),
MyoD (C and D), or Myogenin (E, F, G, H, I, and J).
Arrowheads and asterisks point to clustering defects in
the mutant forelimbs (J) compared to the controls (I).
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Figure 6. Expression Profiles of SLRP Genes in the Forelimbs Identify ICT Subdomains
Dorsal view of wild-type forelimbs at E11.5 (A, C, E, and G) and E12.5 (B, D, F, and H) processed with probes for Lum (A and B),Dcn (C and D), Kera (E and F), and
Epyc (G and H) by whole mount in situ hybridization. Co-localization of SLRP expression with muscle cells were detected by section in situ hybridization followed
by immunofluorescence for Myogenin at E12.5 (I–P) and shown at 103 magnification (I, K, M, and O). The region boxed in 103 panels is shown at 403
magnification (J, L, N, and P).SLRPProteins AreEnriched inMCT/ICTProgenitors and
Identify Distinct ICT Subdomains
The lack of ICT markers has limited progress in understanding
the functions of this tissue. To tackle this problem, we carried
out a transcriptome screen to identify markers of the ICT that
may also be important in ICT function.We combined theOsr2Cre
allele with the ROSAYFP reporter transgenic to render the ICT
cells GFP positive and then used fluorescence-activated cell
sorting (FACS) to isolate the GFP-positive and -negative popula-
tions from limb buds at E11.5 and E12.5 (Figure S3A; STAR
Methods). We then compared the transcriptome of these cell
populations using RNA sequencing (RNA-seq). This screen suc-
cessfully identified many new markers of ICT, and gene lists
were particularly enriched for members of the SLRP family (Fig-
ure S3B; data not shown). SLRPs are ECM molecules that can
bind various types of collagens, cytokines including transforming
growth factor b (TGF-b), and several signaling receptors and
regulate collagen fibrillogenesis, fibril organization, and matrix
assembly, as well as cell proliferation, adhesion, migration, and
differentiation (Merline et al., 2009). We confirmed the expres-
sion of Keratocan (Kera), Decorin (Dcn), Lumican (Lum), Epiphy-
can (Epyc), Fibromodulin (Fmod), and Osteoglycin (Ogn) by RNA
in situ hybridization in whole-mount limb buds at E11.5 and
E12.5 and on E12.5 sections (Figures 6 and S4). We chose to
focus on stages E11.5 to E12.5, as our previous genetic studies
demonstrated this to be a critical window of Tbx5 activity in the3560 Cell Reports 30, 3552–3565, March 10, 2020ICT (Hasson et al., 2010) and this is the time frame when the first
indication of muscle bundle individuation becomes apparent
(Figure 1). Each SLRP has a unique expression pattern and is
not expressed uniformly throughout the ICT but instead in sub-
domains of the limb ICT (Figure 6; Figure S4), which is more
obvious when analyzed in sections (Figures 6I–6P; Figures
S4D, S4E, S4I and S4J). Lum has a broader expression domain,
predominantly because of its proximal limb expression, where it
is either exclusively expressed (Figure 6I) or overlaps with Dcn,
Kera, and Epyc. In addition, Lum is also expressed in the zeugo-
podal domain along with the largely zeugopodally expressed
Dcn, Kera, and Ogn (Figure 6; Figure S4). SLRP subdomains
can also be largely non-overlapping, for example Dcn and Kera
(Figures 6K and 6M). Fmod has a distal expression domain
compared to other tested SLRPs, and it is also expressed in
the ectoderm (Figures S4A–S4D). To co-localize ICT and muscle
precursors, in the same section, RNA in situ hybridization on
sections for SLRP transcripts was followed by immunohisto-
chemistry for myogenin. Lum, Dcn, and Ogn are expressed in
ICT surrounding and embeddedwithin some, but not all, nascent
muscle bundles. Ker, Epyc, and Fmod are more restricted to the
ICT surrounding nascent bundles and are less obvious within
coalescing groups of muscle precursors.
We also analyzed the expression pattern of selected SLRPs in
the forelimbs of Tbx5lx/lx;Osr2Cre homozygous conditional
mutant embryos to establish if deletion of Tbx5 had any effect
Figure 7. SLRP Expression Domains Are Altered in Tbx5lx/lx;Osr2Cre
Mutants
Dorsal view of wild-type forelimbs (A, E, and I) and hindlimbs (B, F, and J), and
mutant forelimbs (C, G, and K) and hindlimbs (D, H, and L) between E12 to
E12.5 processed for Dcn (A–D), Lum (E–H), and Kera (I–L) whole mount in situ
hybridization. Arrow and arrowhead indicates the ectopic domain of Dcn and
absence of its expression in the posterior zeugopodal region in mutant,
respectively (C). Arrows in (E) and (I) show the central zeugopodal domain
where Lum and Kera are generally excluded or expressed at low levels and
arrows in (G) and (K) show the ectopic expression of these SLRPs in the central
domain.on their expression domains (Figure 7). We processed the
cognate hindlimb of each control (Tbx5lx/+;Osr2Cre heterozy-
gous) andmutant forelimb to serve as an internal staging control.
Although the expressions of the SLRPs analyzed were consis-
tent across hindlimb samples, alteration in the expression
domains of Dcn, Lum, and Kera were detected in mutant fore-
limbs compared to controls (Figure 7). A restricted, ectopic
domain of Dcn is observed (Figure 7C, arrow), whereas one of
the normal domains was absent (Figure 7C, arrow). Lum and
Kera, which are both normally excluded from a central zeugopo-
dal domain (Figure 7E, 7I, arrow), are ectopically expressed in
this region in the mutants (Figures 7G and 7K). Together, these
results demonstrate that SLRP expression domains are disrup-
ted following deletion of Tbx5 in ICT.
DISCUSSION
We define the dynamic course of cellular events that lead to the
formation of distinct limb muscle bundles. These include a pro-
gressive series of cell orientation, clustering, and compaction
to form muscle bundles that, in some cases, undergo a further
cleavage step.We demonstrate that themajority of limbmuscles
are formed through a process of orientation of precursor muscle
myofibers, which prefigures subsequent clustering and compac-
tion to form individual muscle bundles. These events occur as
myofibers are undergoing terminal differentiation. This observa-
tion of orientation of muscle fibers prior to muscle bundle forma-
tion is consistent with studies of the chick hindlimb (Kardon,
1998; Schroeter and Tosney, 1991a, 1991b). Our Central Mo-
ments analysis extends these observations and describes the
dynamic process of fiber orientation in which collections of fibers
initially orientated in many directions (more isotropic) become
organized into groups with parallel fibers in the same direction
(increasingly anisotropic). Significantly, our analysis shows that
initially large domains of fibers with similar orientation planes
are present that encompass the precursors of multiple, individ-
ual, future muscle bundles. These larger domains of fibers are
progressively refined into smaller cohorts of fibers with common
orientation planes that prefigure individual muscle bundles or
pre-muscle bundles that subsequently undergo cleavage. The
process of forming individual muscle bundles is often referred
to as muscle splitting or cleavage (Schroeter and Tosney,
1991a, 1991b), and recent studies have implicated vascular
endothelial growth factor (VEGF) signaling from endothelial cells
to be critical for this process (Tozer et al., 2007). Here, we show
that the event that can be considered as muscle splitting (the
cleavage of a single, coherent aggregate of muscle fibers into
two smaller parts) is a later refinement event that contributes
to the individuation of aminority of limbmuscles.We show a spe-
cific example of cleavage from a single parental bundle in the
dorsal/extensor compartment of the zeugopod that generates
the ECRl and ECRb muscles. The earliest phases of muscle
bundle formation occur in a consistent pattern, suggesting the
series of events controlling this process are tightly regulated
and are responsible for the regular array of muscle bundles
that are formed by the end of primary myogenesis (around
E14.5). Later events ofmyogenesis enlarge and refine themature
pattern of individual muscle bundles.Cell Reports 30, 3552–3565, March 10, 2020 3561
By deleting Tbx5 specifically in the ICT/MCT, we show that
partial disruption of the cellular events we describe that lead to
muscle individuation has predictable and reproducible effects
on the final size and shape of muscle bundles and can, in
some cases, lead to the absence of muscle bundles. A role for
MCT in limb soft tissue morphogenesis has been shown previ-
ously (Hasson et al., 2010; Kardon et al., 2003). More recently,
recent studies have proposed molecular mechanisms for how
MCT may act through both ECM and signaling pathways, such
as Cxcl12/Cxcr4, to affect muscle precursor migration and pro-
liferation (Vallecillo-Garcı´a et al., 2017). Here, we identify some of
the early cellular events regulated by the MCT that control mus-
cle morphogenesis and that can become disrupted in the
absence of Tbx5 activity. Correct orientation of muscle fibers is
disrupted in Tbx5mutants with compromised MCT/ICT function,
indicating the importance of MCT/ICT for this early step in mus-
cle morphogenesis. Because orientation of muscle fibers pre-
cedes subsequent steps that further refine individual muscle
bundle formation (our results; Kardon, 1998), disoriented fibers
in the mutants would be predicted to contribute to the observed
muscle patterning defects. Disruption of fiber orientation was
more severely disrupted following genetic ablation of ICT,
corroborating the coordination between the muscle cells and
the surrounding connective tissue for the earliest steps ofmuscle
patterning (Hasson et al., 2010; Kardon et al., 2003; Mathew
et al., 2011; Murphy et al., 2011). Our results indicate that at least
some aspects of the muscle hypoplasia/dysplasia seen in HOS
likely arise from a disruption of some of the earliest events of
muscle morphogenesis and that absence of muscle likely occurs
from a failure to form the primordia of the muscle bundles rather
than a subsequent degeneration of a formed muscle bundle.
The presentation of muscle patterning defects following
deletion of Tbx5 in ICT is not identical to what we observed
using a tamoxifen-inducible, pan-mesenchymal cre deleter,
Prx1CreERt2 (Hasson et al., 2010), although these original
mutants were not analyzed to the same level of detail as the
mutants described here. In our analysis of the Tbx5lx/lx;
Osr2Cre homozygous conditional mutant, we have identified
an absence of muscles and a failure of muscle bundle cleav-
age, whereas extra muscle bundles were observed in the
Tbx5lx/lx;Prx1CreERt2 mutants. The differences in phenotype
can most likely be explained by technical differences between
the two approaches. The events of muscle patterning, which
are controlled, in part, through the activity of Tbx5 in ICT/
MCT, occur during a relatively narrow time window, around
E11.5–12.5. Because there are variations in the timing and
extent of cre activity following tamoxifen administration in
each embryo, this factor could significantly impact phenotypes
given the narrow time frame when Tbx5 is required for muscle
patterning. Consistent with this idea, variation in muscle mis-
patterning phenotypes were observed in Tbx5lx/lx;Prx1CreERt2
mutants (Hasson et al., 2010). In marked contrast, use of con-
ventional cre with the Osr2Cre line produced reproducible mus-
cle mispatterning phenotypes, indicating that deletion of Tbx5
within ICT at a fixed time disrupts normal events of muscle
patterning with consistent, predictable outcomes.
We have identified members of a class of molecules, the
SLRPs, which serve as novel markers of ICT/MCT and are3562 Cell Reports 30, 3552–3565, March 10, 2020candidates to have roles in ICT/MCT control of soft tissue
morphogenesis. SLRPs are matricellular proteins that have
well-established roles in modulating matrix assembly (Chen
and Birk, 2013). Several lines of evidence suggest a role for
SLRPs in muscle formation, repair, and disease. SLRPs can
affect several signaling pathways implicated in muscle, for
example myostatin, TGF-b, and insulin growth factor (IGF) (Lee
et al., 2016; Schaefer and Iozzo, 2008; Zhou et al., 2011).
Expression patterns of SLRPs are altered in Duchenne muscular
dystrophy (DMD) and muscle injury (Casar et al., 2004; Fadic
et al., 2006; Zanotti et al., 2005), and Dcn and Fmod have
been implicated in regulating myogenesis (Brandan et al.,
2008; Brandan and Gutierrez, 2013; Jan et al., 2016). Mouse
knockouts for Dcn, Lum, Fmod, and Biglycan (Bgn) have pheno-
types associated with disrupted collagen fibrillogenesis (Ameye
et al., 2002; Chen et al., 2010; Kalamajski and Oldberg, 2010;
Merline et al., 2009). These knockout mice phenotypes are
consistent with SLRPs determining the architecture and the me-
chanical and chemical properties of the ECM. Abnormalities in
limbmusculature have not been described in these SLRPmouse
mutants. A possible explanation is that several SLRPs have
redundant or partially redundant roles in ICT, similar to that
described for SLRPs Dcn and Bgn acting in the skin and cornea.
Because we have shown that defective MCT affects muscle
morphogenesis (Figure 4; Hasson et al., 2010), it is potentially
significant that MCT is rich in this family of matrix-modifying pro-
teins. Strikingly, the SLRPs we identified are not expressed uni-
formly throughout the ICT but in distinct, partially overlapping
domains, suggesting a particular signature of SLRP expression
may provide a pattern/cue to the nascent muscle bundle tissue
precursors through local modulation of signaling pathways
and/or ECM matrix. Although our results do not ascribe func-
tional significance to SLRPs, they identify SLRPs at minimum
as useful MCT/ICT markers and reveal a pattern or regionaliza-
tion within the MCT/ICT that could define the territories where
distinct muscle bundle primordia will form. The potential exis-
tence of MCT subdomains has been proposed (Orgeur et al.,
2018; Sefton and Kardon, 2019). Our study provides the first
molecular distinction that MCT/ICT subdomains do exist around
the nascent limb musculature. This is particularly evident in the
expression patterns of Ker (class II), Lum (class II), and Dcn
(class I) and the highly restricted pattern of Epyc (class III) (Fig-
ure 6). SLRPs from the same class compete for the same bind-
ing site on collagen (Chen and Birk, 2013); therefore, these
unique and dynamic SLRP expression domains could be func-
tionally relevant (Figure 6; Figure S4). Although, the differential
expression or functions of SLRPs have not been reported for
the limb, the importance of unique combinations of SLRPs in
generating transparency of the cornea has been described
(Carlson et al., 2005; Chakravarti et al., 1998; Chen et al.,
2014). By analogy to their function in cornea, it is possible that
different combinations of SLRPs expressed in distinct MCT/
ICT domains surrounding nascent muscle bundles modulate
ECM content around muscle precursors and, thereby, influence
local cellular behavior (Thorsteinsdo´ttir et al., 2011) and individ-
ual muscle bundle formation. In addition to affecting the physical
architecture of the ECM, SLRPs could also affect the movement
and presentation of secreted signaling molecules in the ECM,
thereby altering the cellular micro-environment and influencing
muscle precursor proliferation, migration, and differentiation
(Chen and Birk, 2013; Chen et al., 2010, 2014; Schaefer and
Iozzo, 2008; Brandan et al., 2008; Dellett et al., 2012; Lorda-
Diez et al., 2014; Nikitovic et al., 2012). SLRPs are known to
interact with various cytokines and cell surface receptors,
including, but not limited to, BMP4, TGF-b, IGF-IR, and integrin
a2b1 (Merline et al., 2009; Schaefer and Iozzo, 2008). Our cur-
rent results do not distinguish whether one or both of these
mechanisms are significant in the effect of MCT on muscle
bundle formation. However, alterations in the expression pattern
of SLRPs in the Tbx5mutant limbs (Figure 7) are consistent with
them having roles in limb soft tissue morphogenesis and disrup-
tion of their activity contributing to soft tissue defects.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All regulated work using animal model (mouse) was carried out under the appropriate UK Home Office Animal (Scientific Procedures)
Project Licence (Holder: Malcolm P.O. Logan) and was reviewed and approved internally through the local Ethical Review Panels
(ERP) at King’s College London.
Tbx5lox/lox strain is originally described in Bruneau et al. (2001).
ROSA26YFP (Gt(ROSA)26Sortm1(EYFP)Cos) reporter transgenic is originally described in Srinivas et al. (2001).
Osr2IREScre (Osr2tm2(cre)Jian) is originally described in Lan et al. (2007).
ScxGFP strain is originally reported in Pryce et al. (2007).
Z/AP (CAG-Bgeo/ALPP)1Lbe) reporter transgenic is originally described in Lobe et al. (1999).
ROSA-eGFP-DTA (Gt(ROSA)26Sortm1(DTA)Jpmb) is originally described in Ivanova et al.( 2005).
METHOD DETAILS
Transgenic mice and embryos
Mouse embryos were staged according to Kaufman (Baldock et al., 2001) and the web tool https://dmdd.org.uk/. Noon on the day a
vaginal plug was observed was taken as E0.5 day gestation. The mouse lines used have been described previously; Tbx5 (Bruneau
et al., 2001), Rosa26YFP (Srinivas et al., 2001) Osr2IRESCre (Lan et al., 2007), ScxGFP (Pryce et al., 2007), Z/AP (Lobe et al., 1999),
ROSA26-eGFP-DTA (Ivanova et al., 2005). Tbx5 lx/+;Osr2Cre heterozygotes are viable and fertile and were used as controls for
comparison with Tbx5lx/lx;Osr2Cre mutants. A minimum of 3 limbs were analysed for each condition.
Genotyping
Lox, wild-type and Cre alleles were identified by conventional PCR genotyping as previously described (Minguillon et al., 2005) and
using the TwistAmpR exo system (TwistDx, UK) following the manufacturer’s instructions. Primers used for Twist amplification were:
Tbx5loxsiteFWD ATAACTTCGTATAATGTATGCTATACGAGT[T(TAMRA)]HTC[T(BHQ-2)]AGTTGTGTGCCTTC
Tbx5WTsiteFWDFAM CGAGGTATGGGGGAGCCGAGTTCTGTACTAGT[T(FAM)]HTG[T(BHQ-1)]GCCTTCAGCTTTC
The presence of ScxGFP and Osr2Cre;RosaYFP transgenes was identified by examination of the limbs under fluorescent light.
FACS and Cell Culture
Tbx5lx/+;Osr2Cre;RosaYFP and Tbx5lx/lx;Osr2Cre;RosaYFP embryos were harvested in cold DMEM/F12-10%FBS-1%glutamax.
Genotyping of each embryo was performed using the TwistAmpR exo system after digestion of tissue for 20 min at 95C. Forelimbs
were collected and cells dissociated in collagenase/dispase 0.5mg/ml. Cells suspensions were sorted to obtain YFP positive
and YFP negative cells fractions by FACS at 4C using a BD Influx cell sorter (laser 488nm) at 32psi sample pressure, 30 psi
sheath fluid, 86 microns nozzle. Both fractions were collected in DMEM/F12-10%FBS. For culture, cells were plated on
CorningRCellBINDRSurface plates in DMEM/10%FBS/1%L-Glutamine/1%Pen-strep.Cell Reports 30, 3552–3565.e1–e6, March 10, 2020 e2
RNA In Situ Hybridization
Whole-mount and section in situ hybridization were carried out essentially as previously described (Riddle et al., 1993). Aminimum of
three mutant embryos were analysed at each stage described with each probe. Pax3, MyoD, Myog, Scx (Hasson et al., 2010), Dcn
(Image clone 40130798), Kera (Image clone 40046884), Lum (Image clone 3582135), Epyc, (Image clone 4037028 ), Fmod (Image
clone 30058603), and Ogn (Image clone 5067073).
The protocol on cryosections was carried out essentially as described by Riddle et al. (1993) with the following amendments to
detect mRNA trancripts.
- leave the slides dry on the bench for 30 minutes, RT.
- 30 min in PBS1X (in a clean rack, washed before with detergent and RNAse easy).
- 10 min in PFA4% then 2x5min in PBS
- prehybrydisation 2h at RT in a humidified box soaked in SSC1X-50%formamide (from SSC20X pH7), 500 ml prehybridization
solution per slide.
- in a tube, mix 100ml of prehyb solution + 1-3 ml of the probe and put it at 80C for 10min, then immediately on ice for 5min.
- remove prehyb solution from the slide
- spread the hybridisation solution (prehyb + probe) on the slide and cover with RNAse free glass coverslip.
- incubate O/N 70C in a hybridisation oven, no shaking, in a sealed humidified box (made wet with 1xSSC-50% formamide).
washes :
- 1 X in 50%formamide;1xSSC;0.1% Tween at 65C to remove the coverslips (in a large volume, pull the slide with forceps, the
coverslips usually fall down themselves with the heat but if not, help them pushing gently towards the bottom of the slide)
Then further washes as follows:
- 2x30min in 50%formamide-1xSSC-0.1%tween at 65C.
- 2x30min in Maleic acid buffer, RT.
blocking :
- 2h at RT in 2%BBR(Boehringer Blocking reagent-Roche)-20%SS-maleic acid buffer. 500ml/slide
Incubation with anti-dig :
- 1/3000 dilution in 2%BBR-20%Sheep serum in maleic acid buffer, 100ml/slide covered with a piece of parafilm.
- incubate O/N at 4C in a humidified chamber with water.
washes :
- 4x30min in maleic buffer
- 2x15min in NTMT
detection :
- either in a large volume OR with 400-500ml/slide of detection solution, in the dark : 1ml NTMT + 3,4ml NBT (0.075g/ml in
70& DMF + 3.85ml BCIP(Na salt) (0.05 mg/ml in H2O)
can last few hours or several days, depending on the probe.
- once the staining is satisfactory, rinse in NTMT then PBT several times, then quickly in water andmounted in aqueous mounting
medium.
- if the staining needs several days, leave the slides in NTMT O/N at 4C at the end of each day.
Solutions :
prehyb solution : 50% formamide, 5X SSC (3M NaCl; 0.3M NaCitrate), pH 4.5, 1% Sodium dodecyl sulphate (SDS)
maleic acid buffer : 400ml of maleic acid 250mM pH7.2 + 30ml NaCl (5M) + 10ml 10%Tween.
Immunohistochemistry - Optical Projection Tomography and confocal analysis
Immunohistochemistry were performed on 12 microns sections of Osr2Cre;RosaYFP embryos. Sections were left at room temper-
ature for 30minutes then rinsed in PBS for 1h, blocked for 2h in PBS-1%BSA-10%NGS, incubated overnight in primary antibodies at
4C. Sections were then washed quickly in PBS, incubated 2h in the same blocking solution with secondary antibodies and DAPI
(1:2000) and finally washed several times in PBS before mounting in PBS-50%glycerol. Confocal images were produced usinge3 Cell Reports 30, 3552–3565.e1–e6, March 10, 2020
the Zeiss LSM5 Pascal. Whole-mount immunostainings and OPT analyses were done as previously described (DeLaurier et al.,
2006). Whole forelimbs were cleared after staining in 100% glycerol or Focus Clear reagent according to manufacturers’ instructions
(CelExplorer lab) and thenmounted. Confocal imageswere produced using either the Zeiss LSM5Pascal or Leica TCS Sp5 (objective
63x/1.3NA Glycerol (Leica HCX PL APO CS 63x /1.3 GLYC (s/n 11506194)). Identification of skeletal elements, muscles and tendons
was done using the mouse limb anatomy atlas (Delaurier et al., 2008).
The following antibodies were used: mouse anti-skeletal myosin (my32; 1:800; Sigma), mouse anti-myosin heavy chain and sarco-
mere myosin (F59 & MF20; both 1:50 DSHB), mouse anti-MyoD (Dako 1:50 for whole mount, 1:200 for sections), sheep anti-digox-
ygenin (Roche, 1:3000), rabbit anti-Myogenin (5FD, DSHB, 1:10), rabbit anti-GFP (Invitrogen A21311, 1:250), sheep anti-GFP (AbD
Serotec, 1:200) and donkey anti-sheep alexa-488 (Invitrogen 1:300), mouse anti-Sox9 (R&D systems, 1:200), rabbit anti-Tcf4
(Clone C48H11 Cell Signalling Technology 2569, 1:50), Biotin-SP donkey anti-rabbit (Jackson ImmunoResearch 711-065-152,
1:500), Streptavidin conjugated Cy3 (Jackson ImmunoResearch 016-160-084, 1:200), and Alexa Fluor 555 goat anti-mouse IgG
(LifeTechnologies A21422, 1:400).
Basic Whole Mount Immunohistochemistry staining protocol
To obtain deep penetration of antibody staining in whole mount preparation of limbs we used a slightly modified protocol including
DMSO to increase antibody penetration.
Embryos fixed in 4% Paraformaldehyde (PFA).
Embryos were stored in Methanol (100%) before processing.
Limbs are removed from the embryo and (if older than E13.5) skinned (in 100% methanol solution) prior to the staining.
Day 1:
1. Rehydrate limb in 50%Methanol:Phosphate-buffered saline; 0.1% Tween (PBT) 1 x 10min, RT, rocking. (if not fixed previously
in Methanol - go to 50% Methanol/PBT to 100% Methanol for 1h wash then back to 50% and finally PBT)
2. Wash limb in PBT 3 x 5 min, RT, rocking.
3. Incubate limbs in PBT, 1 hr, 700C, rocking (to inactivate endogenous Alkaline phosphatase (AP)). This step only for AP staining.
Omit if fluorescence staining.)
4. Bleach with 6% Hydrogen Peroxide in PBT, 1hr RT, rocking. (Omit if fluorescence staining.)
5. wash in PBT 3 x 5 min. (only necessary if steps 3 and 4 above were carried out)
6. Block 1 hr (Block solution: 1 x PBS; 0.1% Triton; 1% BSA; 0.15% glycine), RT, rocking.
7. antibodies anti myosin : F59 and MF20 both at 1/50 in block solution O/N 40C, rocking
Day 2:
1. wash in PBT 3 x 5 min, RT, rocking.
2. wash in PBT 3 x 1 hr, RT, rocking.
3. Block 1 hr (Block solution: 1 x PBS; 0.1% Triton; 1% BSA; 0.15% glycine), RT, rocking.
4. Incubate antibody anti-mouse-AP (Fc portion) (1:800) + anti-myosin-AP (My32) (1:800) in block solution, overnight, 40C
rocking.
Day 3:
1. wash antibody in TBST 3 x 5 min, RT, rocking.
2. wash antibody in TBST 5 x 1 hr, RT, rocking.
3. leave overnight in TBST (40C) or proceed to detection.
Detection: (AP only)
1. wash 3 x 5 min in NTMT, RT, rocking.
2. Incubate with fresh NBT and BCIP.
3. cover tubes and leave rocking in RT – AP staining is usually visible within 3 minutes but requires longer to go to completion.
postfix: 4% PFA; 0.2% glutaraldehyde.
Solutions
PBS ( 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8 mM KH2PO4)
TBST (0.14M NaCl, 2.7mM KCl, 25mMTrisHCl, pH7.5 1% Tween-20)
NTMT (100mM NaCl, 100mM TrisHCl, pH 9.5, 50mM MgCl2, 0.1% Tween-20)Cell Reports 30, 3552–3565.e1–e6, March 10, 2020 e4
Modifications for Whole mount Immunoflourescence staining
Post-fix/permeabilization samples in Methanol:DMSO (4:1) for 2- 4 weeks.
Block solution: 1 x PBS; 5% goat serum, 20% DMSO
Incubate primary Abs for overnight or up to 1 week at 4C.
Mounting of whole limbs for confocal scanning
To confocal scan the relatively large limb specimens we mounted processed samples on slides in clearing agents.
Stained limbs were placed directly onto a Superfrost slide with a transfer pipette
The majority of the PBS solution was removed
4 drops of petroleum jelly in 4 corners following the dimensions of the coverslip were placed around the sample.
- add 200 ml of Focus Clear on top of the limb
- place a coverslip on top of sample in Focus Clear and gently press flat to create a vaseline seal at the corners. Don’t press to
much but sufficient pressure so the limb is flattened for the confocal scan
- leave the slide at 4C O/N taking care to be sure Focus Clear covers the limb
- after scan, the limb can be stored in PBS, keep at 4C
Clearing whole embryos with clearT
Essentially following the protocol of Kuwajima et al., 2013, Development
After post fixing the immunostaining all steps in the dark:
Remove PBS from samples
Add 25% formamide/10% PEG, 1 hour rocking RT
50% formamide/20% PEG, 1 hour rocking RT
50% formamide/20% PEG, O/N at 4C
The embryos are ready for mounting and imaging.
Caution : Do not store the embryos in formamide. For storage rinse the sample in PBS and store in fresh PBS (azide can be added).
Solutions :
50% formamide/20% polyethylene glycol (PEG): mix formamide (99.6%, considered 100%) with 40%PEG/H2O (wt/vol) at a ratio
of 1:1 (vol/vol).
25% formamide/10% PEG: mix 50% formamide plus 20% PEG/H2O (wt/vol) at a ratio of 1:1 (vol/vol).
40% PEG solution: stir powdered PEG 8000 MW (Sigma-Aldrich) in warm H2O for 30 minutes, (stable at room temperature for
several months)
Determination of muscle orientation values
To analyse orientation, myocytes and nascent fibres were labelled using myogenin and myosin antibodies and the dorsal forelimbs
were scanned using confocal microscopy. Image files generated were opened in the open source software Fiji-ImageJ2 and a
graphic tablet was used to draw a line over the long axis of myogenin andmyosin positive elongated cells, for each individual Z plane,
in a new overlying layer. Each line represents the orientation vector of the cell that we could assign an angle value. These binary
images of manually detected fibres were imported into Wolfram Mathematica (Champaign, IL) where the orientation of fibres
were determined using our own bespoke scripts. Briefly, overlaps between fibres, or morphological branch points, were removed
before orientation analysis was performed using the second order central moments on a fibre-by-fibre basis. Angles were normalised
to a range of 0-to-Pi radians (or 0 to 180) in 32 different bins and colour-coded according to similar orientation using a Hue look up
table.
RNA sequencing and In Silico analysis
Sorted cells from E11.5 and E12.5 Tbx5lx/+;Osr2Cre;RosaYFP and Tbx5lx/lx;Osr2Cre;RosaYFP forelimbs were centrifuged at 500g
5min at 4C. Supernatant was removed and RLT buffer with b-mercaptoethanol was added, transferred to Qiashredder columns
and centrifuged 2min at full speed in a bench centrifuge. The cells were then stored at -80C. RNAs were extracted using the RNeasy
Mini Kit (QIAGEN) according to manufacturers’ instructions. Each sample is a pool of YFP positive or YFP negative forelimb cells at
E11.5 and E12.5. A total of 0.5mg of RNA per sample was used to generate cDNA libraries using the Illumina Truseq RNA sample
preparation V2 kit. A single-read sequencing was done, generating 75bp reads. In total, three independent samples of control
and mutants cells were analysed for each stage and each YFP+ and YFP- fraction.e5 Cell Reports 30, 3552–3565.e1–e6, March 10, 2020
QUANTIFICATION AND STATISTICAL ANALYSIS
Avadis NGS software (Strand NGS.com) was used to align the outcome reads and data analysis. Alignment was done against the
transcriptome with transcript model "Ensembl Genes and transcript". Quantification was performed on all aligned reads using the
DESeq normalization algorithm and genes were filtered by expression with a lower cut off of 10 raw counts. A moderate Student’s
t-test was applied to identify differentially expressed genes in the different cell populations and to generate the given p values. p<0.05
was considered significant andwas used as a threshold. Fold change analysis corresponds to the ratio of the read densities between
two conditions. Its calculation is the antilog of difference in averaged, normalized values between conditions.
DATA AND CODE AVAILABILITY
The FastQ files of the RNA seq data generated in this study are available at ArrayExpress accession E-MTAB-8772.Cell Reports 30, 3552–3565.e1–e6, March 10, 2020 e6
